Liu J, Li H, Hamou M F
Division of Molecular Biology, Shenyang Medical College.
Zhonghua Bing Li Xue Za Zhi. 1996 Jun;25(3):132-4.
In order to analyse the functional importance of leukemia inhibitory factor (LIF) in the prolliferation of human medulloblastoma cells, antisense LIF oligonucleotides were used to block LIF gene expression in established medulloblastoma cell line Med-3. The effects of this measure on Med-3 cells were then investigated by using different approaches. The results revealed that LIF expression in the cells treated by antisense LIF reduced below the threshold being detectable with RT-CPR and anti-LIF immunocytochemistry also showed a negative lebelling. Meanwhile, proliferation rate of antisense treated cells decreased distinctively. In contrast, the LIF gene expression as well as proliferation of Med-3 cells treated by sense oligonucleotides remained similar as that of the normally cultured cells. The data suggest a LIF oriented gene/immune trial for the therapy of medulloblastomas and other LIF growth-associated tumors of humans.
为分析白血病抑制因子(LIF)在人髓母细胞瘤细胞增殖中的功能重要性,采用反义LIF寡核苷酸阻断已建立的髓母细胞瘤细胞系Med-3中的LIF基因表达。然后用不同方法研究该措施对Med-3细胞的影响。结果显示,经反义LIF处理的细胞中LIF表达降低至RT-CPR检测不到的阈值以下,抗LIF免疫细胞化学也显示阴性标记。同时,反义处理细胞的增殖率明显降低。相反,经正义寡核苷酸处理的Med-3细胞的LIF基因表达及增殖与正常培养细胞相似。这些数据提示针对人髓母细胞瘤及其他与LIF生长相关肿瘤的治疗可进行以LIF为导向的基因/免疫试验。